Expired activity

Please go to the PowerPak homepage and select a course.

PHARMACY PrEP EDUCATION A "How To" Series Spanning Policy to Practice
Optimizing PrEP Access Through Advocacy

This activity is jointly provided by Global Education Group and Integritas Communications.
 
This activity is supported by an educational grant from Gilead Sciences, Inc.

Release Date

June 28, 2022

Expiration Date

June 28, 2023

Activity Description

This activity will focus on medication therapy management protocols and their impact on prescription drug coverage policies. It also will look at PrEP access through a health equity lens and will include a review of the drug utilization review process, insurance models, and health impact analysis—considering the impact of each on patients and care.

Target Audience

The educational design of this activity addresses the needs of clinical and community pharmacists involved in the treatment of patients at risk for HIV infection as well as managed care pharmacists, pharmacy benefit managers, and specialty pharmacists.

Educational Objectives

After completing this activity, the participant should be better able to:

• Describe how Medication Therapy Management (MTM) protocols impact prescription drug coverage policies, PrEP access, and health equity
• Review the basics of the Drug Utilization Review (DUR) process and its relationship to and impact on public and private insurance models
• Discuss how PrEP providers, practitioners, and advocates can participate in effective MTM protocols.

Faculty

Melissa Badowski, PharmD, MPH
Clinical Associate Professor
University of Illinois at Chicago, College of Pharmacy

Scott Bertani, MA
Director Of Advocacy
HealthHIV

Pharmacist Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

Credit Designation

Global Education Group designates this continuing education activity for 1.0 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number 0530-9999-22-035-H02-P)

This is a knowledge-based activity.

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

In order to received credit, participants must complete the following:

• Read the educational objectives, accreditation information, and faculty disclosures at the beginning of this activity.
• Complete the Preactivity Questions.
• Review the activity content.
• Achieve a grade of 70% on the Postactivity Test Questions and complete the Evaluation.
• CE credits will be uplaoded to CPE Monitor within 60 days of completion.

Fee Information& Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosures of Conflicts of Interest

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global.  All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias. 

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

The planners and managers have the following relevant financial relationships with ineligible companies:

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Integritas Communications do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.